☰

Vipin Shankar Chelakkot, Ph.D - Publications

Affiliations: 
2007-2008 Chemistry Vellore institute of Technology 
 2008-2010 Biochemistry Muhimbili University 
 2010-2015 Pediatrics Mie University Graduate School of Medicine 
 2015- Division of BioMedical Sciences Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada 
Area:
Cancer Biology, Photodynamic Therapy
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wang L, Chelakkot VS, Newhook N, Tucker S, Hirasawa K. Inflammatory cell death induced by 5-aminolevulinic acid-photodynamic therapy initiates anticancer immunity. Frontiers in Oncology. 13: 1156763. PMID 37854679 DOI: 10.3389/fonc.2023.1156763  0.723
2023 Chelakkot VS, Thomas K, Romigh T, Fong A, Li L, Ronen S, Chen S, Funchain P, Ni Y, Arbesman J. MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression. Npj Precision Oncology. 7: 85. PMID 37679505 DOI: 10.1038/s41698-023-00437-1  0.368
2023 Chelakkot C, Chelakkot VS, Shin Y, Song K. Modulating Glycolysis to Improve Cancer Therapy. International Journal of Molecular Sciences. 24. PMID 36768924 DOI: 10.3390/ijms24032606  0.535
2020 Chelakkot VS, Liu K, Yoshioka E, Saha S, Xu D, Licursi M, Dorward A, Hirasawa K. MEK reduces cancer-specific PpIX accumulation through the RSK-ABCB1 and HIF-1α-FECH axes. Scientific Reports. 10: 22124. PMID 33335181 DOI: 10.1038/s41598-020-79144-x  0.653
2020 Kihira K, Chelakkot VS, Kainuma H, Okumura Y, Tsuboya N, Okamura S, Kurihara K, Iwamoto S, Komada Y, Hori H. Close interaction with bone marrow mesenchymal stromal cells induces the development of cancer stem cell-like immunophenotype in B cell precursor acute lymphoblastic leukemia cells. International Journal of Hematology. PMID 32862292 DOI: 10.1007/s12185-020-02981-z  0.62
2019 Chelakkot VS, Som J, Yoshioka E, Rice CP, Rutihinda SG, Hirasawa K. Systemic MEK inhibition enhances the efficacy of 5-aminolevulinic acid-photodynamic therapy. British Journal of Cancer. PMID 31551581 DOI: 10.1038/S41416-019-0586-3  0.618
2018 Yoshioka E, Chelakkot VS, Licursi M, Rutihinda SG, Som J, Derwish L, King JJ, Pongnopparat T, Mearow K, Larijani M, Dorward AM, Hirasawa K. Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway. Theranostics. 8: 2134-2146. PMID 29721068 DOI: 10.7150/Thno.22641  0.617
2018 Xu DQ, Toyoda H, Yuan XJ, Qi L, Chelakkot VS, Morimoto M, Hanaki R, Kihira K, Hori H, Komada Y, Hirayama M. Anti-tumor effect of AZD8055 against neuroblastoma cells in vitro and in vivo. Experimental Cell Research. PMID 29499203 DOI: 10.1016/j.yexcr.2018.02.032  0.653
Show low-probability matches.